Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes

被引：0
|
作者：
Yi Ren
Lei Chen
Ruochun Guo
Shiyang Ma
Shenghui Li
Yue Zhang
Hongli Jiang
Haitao Shi
Pan Zhang
机构：
[1] the First Affiliated Hospital of Xi’an Jiaotong University,Department of Critical Care Nephrology and Blood Purification
[2] People’s Hospital of Longhua,Department of Nephrology
[3] The Second Affiliated Hospital of Xi’an Jiaotong University,Department of Gastroenterology
[4] Shaanxi Key Laboratory of Gastrointestinal Motility Disorders,undefined
[5] Shaanxi Provincial Clinical Research Center for Gastrointestinal Diseases,undefined
[6] Digestive Disease Quality Control Center of Shaanxi Province,undefined
[7] Puensum Genetech Institute,undefined
来源：
Journal of Translational Medicine | / 22卷
关键词：
End-stage renal disease; Gut mycobiome; Shotgun metagenome sequencing; Serum metabolome; Fecal metabolome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes
    Ren, Yi
    Chen, Lei
    Guo, Ruochun
    Ma, Shiyang
    Li, Shenghui
    Zhang, Yue
    Jiang, Hongli
    Shi, Haitao
    Zhang, Pan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [2] Characterization of the gut mycobiome composition in patients with end-stage renal disease
    Wang, Mengxiao
    Wang, Ting
    Xia, Chenyan
    Zhi, Yingxin
    Zhao, Zhanzheng
    Shang, Jin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [3] Characterization of the gut mycobiome composition in patients with end-stage renal disease
    Wang, Mengxiao
    Wang, Ting
    Xia, Chenyan
    Zhi, Yingxin
    Zhao, Zhanzheng
    Shang, Jin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2195 - I2197
  • [4] Hepatic Clearance, but Not Gut Availability, of Erythromycin Is Altered in Patients With End-Stage Renal Disease
    Sun, H.
    Frassetto, L. A.
    Huang, Y.
    Benet, L. Z.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) : 465 - 472
  • [5] Correlations between serum inflammatory markers and comorbidities in patients with end-stage renal disease
    Eloueyk, Asmahan K.
    Alameddine, Rashad Y.
    Osta, Bilal A.
    Awad, Dania M.
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2019, 14 (06): : 547 - 552
  • [6] Altered sleep structure in patients with end-stage renal disease
    Elias, Rosilene M.
    Chan, Christopher T.
    Bradley, T. Douglas
    SLEEP MEDICINE, 2016, 20 : 67 - 71
  • [7] Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
    Moradi, Hamid
    Park, Christina
    Igarashi, Miki
    Streja, Elani
    Argueta, Donovan A.
    Soohoo, Melissa
    Daglian, Jennifer
    You, Amy S.
    Rhee, Connie M.
    Kashyap, Moti L.
    DiPatrizio, Nicholas, V
    Vaziri, Nosratola D.
    Kalantar-Zadeh, Kamyar
    Piomelli, Daniele
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (10) : 1869 - 1880
  • [8] Serum Levels of Omentin in End-Stage Renal Disease Patients
    Alcelik, Aytekin
    Tosun, Mehmet
    Ozlu, Mehmet Fatih
    Eroglu, Mustafa
    Aktas, Gulali
    Kemahli, Eray
    Savli, Haluk
    Yazici, Mehmet
    KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 35 (06): : 511 - 516
  • [9] Serum magnesium and end-stage renal disease
    Hutchison, AJ
    PERITONEAL DIALYSIS INTERNATIONAL, 1997, 17 (04): : 327 - 329
  • [10] Adipokines and gut hormones in end-stage renal disease
    Mak, Robert H.
    Cheung, Wai
    PERITONEAL DIALYSIS INTERNATIONAL, 2007, 27 : S298 - S302
12345